CHM — Chimeric Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- AU$0.16m
- -AU$0.64m
Brief: Chimeric Therapeutics Says Board & Management Commit To A$1.04M Placement
Brief: Chimeric Therapeutics Says Patent Granted In India For Cltx Car Technology
Australia's Chimeric Therapeutics leaps on positive FDA feedback for cancer therapy
Brief: Chimeric Therapeutics Got Positive Feedback On Development Plan For CHM 2101 at Pre-IND Meeting With U.S. FDA
Brief: Chimeric Therapeutics Ltd Says HY Loss For The Period A$11.7 Mln Versus Loss Of A$9.7 Mln
Chimeric Therapeutics jumps most in 3 weeks on cell therapy study progress
Australia's Chimeric Therapeutics jumps on exclusive license agreement
Brief: Chimeric Therapeutics Says FY Loss A$14.6 Mln
Australia's Chimeric rises as co expands license deal with University of Pennsylvania
Brief: Chimeric Therapeutics Says Expanded Its License Agreement With University Of Pennsylvania
Brief: Chimeric Therapeutics Enters A$30 Million Equity Placement Agreement With L1 Capital
Brief: Chimeric Therapeutics Says It Entered Manufacturing Partnership With Wuxi ATU
Australia's Chimeric Therapeutics climbs on WuXi AppTec unit partnership
Australia Stock Exchange release from CHIMERIC THERAPE : CHMO - PRE_NR Ends: 09:07:40
Australia Stock Exchange release from CHIMERIC THERAPE : Security Class Reinstatement to Quotation CHMO
Australia Stock Exchange release from CHIMERIC THERAPE : Entitlement Offer Option Exercise Form
Australia Stock Exchange release from CHIMERIC THERAPE : Appendix 2A (amended)
Australia Stock Exchange release from CHIMERIC THERAPE : Appendix 2A
Australia Stock Exchange release from CHIMERIC THERAPE : PRE_NR Ends: 10:00:25